Written answers
Thursday, 25 October 2018
Department of Health
Rare Diseases Strategy
Lisa Chambers (Mayo, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
252. To ask the Minister for Health the details of the chair and composition of the technical review committee on rare diseases; and his views on whether a conflict of interest exists between the independent NCPE and the technical review committee. [44418/18]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.
Lisa Chambers (Mayo, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
253. To ask the Minister for Health the terms of reference for the technical review committee on rare diseases; and the timeline for review. [44419/18]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments